Researchers from the University of Glasgow and collaborators in Barcelona developed a wearable mini-pump that safely delivers medication to heart-failure patients.
This development matters because it allows patients to receive critical diuretic treatment at home, potentially reducing the burden on hospital bed capacity and improving patient quality of life.
The device is designed to deliver furosemide, a diuretic medication used to remove excess fluid from the body. By transitioning this treatment to a wearable format, the study found that patients could be discharged from the hospital earlier than they would be under traditional care settings.
The trial was conducted across 20 hospitals [1] in the United Kingdom. The results indicate that the wearable pump is both safe and effective for the target patient population, providing a viable alternative to intravenous administration in a clinical ward.
By enabling the administration of furosemide outside of a hospital environment, the device aims to minimize the time patients spend in medical facilities. This shift in delivery allows for a more flexible recovery process and reduces the physical and mental strain associated with long-term hospitalization.
Collaborators from Barcelona worked alongside the Glasgow team to refine the technology. The partnership focused on ensuring the device remained comfortable for the wearer while maintaining the precise dosage required for heart-failure management.
“A wearable mini-pump that delivers the diuretic furosemide was shown to be safe and effective”
The shift toward wearable medication delivery represents a broader trend in decentralizing healthcare. By moving acute treatments like diuretic therapy from hospital wards to the home, health systems can increase bed turnover and reduce the operational costs of long-term inpatient stays while potentially improving patient recovery outcomes through increased comfort.
